Optimizing the Quality of 4D-DSA Temporal Information.


Journal

AJNR. American journal of neuroradiology
ISSN: 1936-959X
Titre abrégé: AJNR Am J Neuroradiol
Pays: United States
ID NLM: 8003708

Informations de publication

Date de publication:
12 2019
Historique:
received: 20 07 2019
accepted: 03 09 2019
pubmed: 2 11 2019
medline: 14 7 2020
entrez: 2 11 2019
Statut: ppublish

Résumé

Quantification of blood flow using a 4D-DSA would be useful in the diagnosis and treatment of cerebrovascular diseases. A protocol optimizing identification of density variations in the time-density curves of a 4D-DSA has not been defined. Our purpose was to determine the contrast injection protocol most likely to result in the optimal pulsatility signal strength. Two 3D-printed patient-specific models were used and connected to a pulsatile pump and flow system, which delivered 250-260 mL/min to the model. Contrast medium (Isovue, 370 mg I/mL, 75% dilution) was injected through a 6F catheter positioned upstream from the inlet of the model. 4D-DSA acquisitions were performed for the following injection rates: 1.5, 2.0, 2.5, 3.0 and 3.5 mL/s for 8 seconds. To determine pulsatility, we analyzed the time-density curve at the inlets using the oscillation amplitude and a previously described numeric metric, the sideband ratio. Vascular geometry from 4D-DSA reconstructions was compared with ground truth and micro-CT measurements of the model. Dimensionless numbers that characterize hemodynamics, Reynolds and Craya-Curtet, were calculated for each injection rate. The strongest pulsatility signal occurred with the 2.5 mL/s injections. The largest oscillation amplitudes were found with 2.0- and 2.5-mL/s injections. Geometric accuracy was best preserved with injection rates of >1.5 mL/s. An injection rate of 2.5 mL/s provided the strongest pulsatility signal in the 4D-DSA time-density curve. Geometric accuracy was best preserved with injection rates above 1.5 mL/s. These results may be useful in future in vivo studies of blood flow quantification.

Sections du résumé

BACKGROUND AND PURPOSE
Quantification of blood flow using a 4D-DSA would be useful in the diagnosis and treatment of cerebrovascular diseases. A protocol optimizing identification of density variations in the time-density curves of a 4D-DSA has not been defined. Our purpose was to determine the contrast injection protocol most likely to result in the optimal pulsatility signal strength.
MATERIALS AND METHODS
Two 3D-printed patient-specific models were used and connected to a pulsatile pump and flow system, which delivered 250-260 mL/min to the model. Contrast medium (Isovue, 370 mg I/mL, 75% dilution) was injected through a 6F catheter positioned upstream from the inlet of the model. 4D-DSA acquisitions were performed for the following injection rates: 1.5, 2.0, 2.5, 3.0 and 3.5 mL/s for 8 seconds. To determine pulsatility, we analyzed the time-density curve at the inlets using the oscillation amplitude and a previously described numeric metric, the sideband ratio. Vascular geometry from 4D-DSA reconstructions was compared with ground truth and micro-CT measurements of the model. Dimensionless numbers that characterize hemodynamics, Reynolds and Craya-Curtet, were calculated for each injection rate.
RESULTS
The strongest pulsatility signal occurred with the 2.5 mL/s injections. The largest oscillation amplitudes were found with 2.0- and 2.5-mL/s injections. Geometric accuracy was best preserved with injection rates of >1.5 mL/s.
CONCLUSIONS
An injection rate of 2.5 mL/s provided the strongest pulsatility signal in the 4D-DSA time-density curve. Geometric accuracy was best preserved with injection rates above 1.5 mL/s. These results may be useful in future in vivo studies of blood flow quantification.

Identifiants

pubmed: 31672837
pii: ajnr.A6290
doi: 10.3174/ajnr.A6290
pmc: PMC6975361
doi:

Substances chimiques

Contrast Media 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2124-2129

Subventions

Organisme : NHLBI NIH HHS
ID : R01 HL116567
Pays : United States

Informations de copyright

© 2019 by American Journal of Neuroradiology.

Références

Med Phys. 2018 Oct;45(10):4510-4518
pubmed: 30102773
J Neurointerv Surg. 2018 Mar;10(3):285-289
pubmed: 28385725
AJNR Am J Neuroradiol. 2014 Jan;35(1):156-63
pubmed: 23928145
J Neurointerv Surg. 2018 Aug;10(8):780-783
pubmed: 29203732
AJNR Am J Neuroradiol. 1998 Aug;19(7):1303-7
pubmed: 9726473
IEEE Trans Med Imaging. 2010 Jun;29(6):1238-51
pubmed: 20172817
Interv Neuroradiol. 2016 Feb;22(1):76-83
pubmed: 26515700
AJNR Am J Neuroradiol. 2018 Oct;39(10):1871-1877
pubmed: 30213811
Radiology. 1979 Jan;130(1):49-57
pubmed: 364537
Med Phys. 2000 Sep;27(9):2008-23
pubmed: 11011728
AJNR Am J Neuroradiol. 2013 Oct;34(10):1914-21
pubmed: 23620072
Med Phys. 2009 Nov;36(11):5064-78
pubmed: 19994517
IEEE Trans Med Imaging. 2000 May;19(5):391-403
pubmed: 11021683
J Neurointerv Surg. 2018 Jun;10(6):580-586
pubmed: 28993442
Comput Med Imaging Graph. 2005 Oct;29(7):507-20
pubmed: 16140501

Auteurs

K L Falk (KL)

From the Department of Biomedical Engineering (K.L.R.) klruedinger@wisc.edu.

E C Harvey (EC)

Department of Medical Physics (E.H., M.A.S.).

S Schafer (S)

Siemens Healthineers Forchheim Germany (S.S.), Hoffman Estates, Illinois.

M A Speidel (MA)

Department of Medical Physics (E.H., M.A.S.).

C M Strother (CM)

Department of Radiology (C.M.S.), University of Wisconsin-Madison, Madison, Wisconsin.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH